Farnesylation is an important post-translational protein modification in eukaryotes. Farnesylation is performed by protein farnesyltransferase, a heterodimer composed of an a-(FTa) and a b-subunit. Recently, homodimerization of truncated rat and yeast FTa has been detected, suggesting a new role for FTa homodimers in signal transduction. We investigated the putative dimerization behaviour of human and rat FTa. Different in vitro and in vivo approaches revealed no self-dimerization and a presumably artificial formation of homotrimers and higher homo-oligomers in vitro. Our study contributes to the clarification of the physiological features of FTase in different species and may be important for the ongoing development of FTase inhibitors.
Protein prenylation is a post-translational modification, controlling the localization as well as the activation of a variety of proteins [1] . Typically, prenylation leads to membrane association of proteins and enables their function in cell signalling pathways [2, 3] . In eukaryotes, three different enzymes, namely the farnesyltransferase (FTase) (EC 2.5.1.58) and two geranylgeranyltransferases (GGTase I (EC 2.5.1.59) and II (EC 2.5.1.60)) are able to perform protein prenylation [4, 5] . FTase and GGTase I catalyse the post-translational attachment of a farnesyl (15C) and geranylgeranyl (20C) group via thioether linkage to a cysteine near the carboxyl terminus of so called CAAX-box proteins [1, [6] [7] [8] . FTase and GGTase I are both heterodimers with unique b-subunits but an identical a-subunit (FTa) [8, 9] . The bsubunits harbour the catalytic centres and determine the prenyl residue as well as protein specificity of the enzymes [10] . Nevertheless, both enzymes show only activity when FTa is present [11] . FTa is tightly associated with the b-subunit of FTase (FTb) forming a very stable heterodimer and significantly increasing each other's post-translational stability [12] . Furthermore, FTa is necessary for interaction of the FTase heterodimer with other proteins like microtubules and cytoplasmic deacetylase [13] . It has additional regulatory function due to direct protein interaction and altered phosphorylation states [13, 14] . Recently, Kubala et al. [15] observed that the truncated a-subunit of Rattus norvegicus (FTaDN29) and full FTa of Saccharomyces cerevisiae are able to form homodimers and assumed FTa might be involved in further intracellular signalling pathways. Until now, it is unknown whether the human FTa has comparable properties. Therefore, the aim of this study was to explore the putative self-binding properties of the human FTa by different in vitro and in vivo approaches.
Materials and methods

Cloning and heterologous expression in E. coli
Escherichia coli strains DH5a (Thermo Fisher Scientific, Waltham, MA, USA), BL21-CodonPlus(DE3)pLysS and Rosetta(DE3)pLysS (both Novagen, Darmstadt, Germany) for cloning and expression studies were cultured under standard conditions following the instructions of the manufacturers.
The coding regions of human FTa (FNTA) cloned in pETDuet1 (kindly provided by Gerrit Praefcke, Paul-Ehrlich-Institute, Langen, Germany) and FTb (FNTB) as well as rat Fnta and Fntb (both in pExpress1, Source BioScience, Nottingham, UK) were amplified via PCR using Pfu polymerase (Thermo Fisher Scientific). The vectors used, antibiotic resistances, primer sets and restriction sites are summarized in Table 1 . For the vector construct pcDNA3.1+::FNTB, the coding region was cloned in pGEM-T Easy with the following primers: forward primer ATGGCTTCTCCGAGTTCTTTCACC, reverse primer ATCGCCAGAGCCTGCAACCGACTAG. Afterwards, it was restricted with EcoRI and cloned into pcDNA3.1+. Successful cloning was confirmed by sequencing (Seqlab, G€ ottingen, Germany). Heterologous expression was carried out in E. coli BL21-CodonPlus(DE3)pLysS (pGEX::FNTA, pGEX::Fnta, pGEX) and E. coli Rosetta(DE3)pLysS (pETDuet1::FNTA, pETDuet1::FNTB, pETDuet1::FNTB/ FNTA, pETDuet1::Fnta) pET expression system (Novagen). Cells were grown in LB-medium at 37°C containing the appropriate antibiotics. Expression was induced by addition of 1 mM isopropyl-1-thio-b-D-galactopyranoside at an OD 600 of~0.5 (and 0.5 mM ZnSO 4 for cells transformed with FNTA and FNTB). After induction, cells were grown for 4 h, harvested by centrifugation (6000 g, 4°C, 15 min) and stored at À80°C.
Purification of recombinant enzymes
Affinity chromatography with Ni-NTA was used to purify His-tagged prey proteins for GST pull-down and in vitro crosslinking. E. coli cells were suspended (3 mL/1 g wet cell weight) in buffer A (50 mM Tris/HCl, pH 7.5, 300 mM KCl, 10 mM MgCl 2 , 10 lM ZnCl 2 , 20 mM imidazole, 5 mM DTT, for GST pull-down experiments) or buffer B (100 mM sodium phosphate buffer, 150 mM NaCl, 10 lM ZnCl 2 , for crosslinking) and lysed by sonification (5 9 3 min) in an ice ethanol bath. Cell debris and unbroken cells were removed by centrifugation (18 600 g, 30 min, 4°C). The lysate was applied to a Ni-NTA IMAC (immobilized metal ion affinity chromatography) column (Qiagen, Hilden, Germany) equilibrated with 3 9 5 mL of buffer A and B, respectively. The flow through was applied five times to the column by gravity flow. After washing (3 9 10 mL buffer A or B by gravity flow), the column was incubated on ice for 5 min with 200 lL buffer AE (buffer A, 250 mM imidazole, for GST pull-down) or BE (buffer B, 250 mM imidazole, for crosslinking) and eluted by gravity flow. For the purification of GST-tagged proteins as prey proteins for His pull-down experiments, the MagneGST purification system (Promega, Mannheim, Germany) was used. E. coli cells (0.5 g wet cell weight) were dissolved in 500 lL MagneGST cell lysis reagent (adding 3-5 U RNase free DNase) and incubated on a shaking plate (4°C, 30 min). Magnetic beats were equilibrated according to the manufacture's protocol with slight modifications (400 mM NaCl in binding/washing buffer). For binding, the beats were incubated with GST or FTa-GST lysate (4°C, 30 min, shaking plate) and washed five times in binding/washing buffer. Proteins were eluted by incubation in 200 lL elution buffer [5 min, room temperature (RT), rotating plate] containing 50 mM glutathione.
Pull-down assays
For His pull-down assays, cells were treated as described above but instead of direct elution, purified proteins (GST and FTa-GST, respectively) were incubated with Histagged proteins already bound to the Ni-NTA resin (RT, 1 h, rotating plate). After washing (3 9 10 mL buffer A, gravity flow), the sample was incubated on ice for 5 min with 200 lL buffer AE. Elution was performed by gravity flow.
For GST pull-down assays, the cells were treated as described above until the GST-proteins were bound to the beats and washed, then charged beats were resolved in 50 lL binding/washing buffer. Purified His-tagged FTa, 40 lL 10% BSA, 50 lL GST-charged beats and washing/ binding-buffer (ad. 400 lL) were incubated (RT, 1 h, rotating plate) and washed five times. Elution was performed as described above. 
Western blot and immunodetection
Yeast two-hybrid
Yeast two-hybrid analysis was carried out using the Matchmaker system 3 (Clontech, Mountain View, CA, USA). Coding regions of FTa and FTb were amplified by PCR and cloned using vectors and primer sets as summarized in Table 1 . Successful cloning was confirmed by sequencing (Seqlab). Protein-protein interactions were detected by cotransformation of S. cerevisiae AH109 with pACT2 and pGBKT7 harbouring FNTA and Fnta, respectively, according to the manufacturer's instruction. In brief, competent AH 109 cells were incubated 5 min at 37°C shaking with 5 lL preheated salmon sperm DNA (Sigma-Aldrich, Munich, Germany; 10 mgÁmL À1 , 10 min, 98°C) and 1 lg of the respective plasmids. Afterwards, 700 lL PEG-bicine solution (40% (w/v) PEG1000, 200 mM bicine, pH 8.35) was added to the cells (1 h, 30°C). The cells were washed in NaCl-bicine (150 mM NaCl, 10 mM bicine), plated on selective SD-medium (-leucine, -tryptophan) and incubated (3 days, 30°C). The interaction of FTa and FTb served as positive control. Resulting colonies were cultivated in liquid SD-medium (-leucine, -tryptophan), grown to an OD 600 of 1.5 and diluted to an OD 600 of 0.1. From this dilution, 5 lL was dropped on SD-plates (-leucine, -tryptophan, -histidine) supplemented with a-X-gal to check for a-galactosidase activity. The transformed yeast cells were also analysed with the colony filter-lift assay to measure b-galactosidase activity according to the manufacturer's handbook (Clontech). Therefore, filter papers (Ø 70 mm; MachereyNagel, D€ uren, Germany) were presoaked with buffer (60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 , 10 mM KCl, 1 mM MgSO 4 , 20 mgÁmL
A dry filter paper was put on the colonies to copy them, placed for~10 s in liquid nitrogen, transferred to the prewetted filters and incubated for 24 h at 30°C in the dark. To increase sensitivity, an a-gal quantitative assay was used [16] . Here, 16 lL supernatant (18 600 g, RT, 5 min) of transformed AH 109 (OD 600 of~1.5) was used for assaying the activity of excreted a-galactosidase. The samples were incubated with 48 lL fresh assay buffer (0.5 M sodium acetate, pH 4.5, 100 mM p-nitrophenyl a-D-galactopyranoside solution (2 : 1 (v/v) ratio) (30°C, 60 min, in the dark). The reaction was stopped by the addition of 136 lL 1 M Na 2 CO 3 and the colorimetric change was measured at 410 nm due to the cleavage of p-nitrophenyl-a-Dgalactopyranoside to p-nitrophenol + D-galactose by agalactosidase. For comparison of a-galactosidase activity, we used a one-way ANOVA and performed Dunnett's multiple comparisons test to compare each group with control.
In vitro protein crosslinking
The oligomerization-state of FTa was analysed by crosslinking 8 lg of proteins after affinity chromatography (as described above) with 50-fold BS3 (bis(sulfosuccinimidyl)-suberate). This was performed according to the manufacturer's protocol (Thermo Fisher Scientific). The reaction was stopped by the addition of 1 M Tris/HCl (pH 7.5, final concentration 50 mM) and the samples applied to a 10% SDS/ PAGE, blotted on a nitrocellulose membrane and analysed like explained above. As positive control, coexpressed FTa and FTb were used. For negative control, 2% beta-mercaptoethanol was added to the reaction mixture.
In vivo protein crosslinking
Human embryonic kidney cells (HEK293) were routinely maintained in Dulbecco's modified Eagle's medium (Gibco Life Technologies, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (Merck Millipore, Darmstadt, Germany), 100 UÁmL À1 penicillin and 100 lgÁmL À1 streptomycin (PAA, Pasching, Austria) in 5% CO 2 atmosphere at 37°C. 4.5-6 9 10 5 cells were split onto six-well plates, grown to 70-80% confluence and transiently transfected in triplicate in serum-free medium by lipofectamine 2000 (Invitrogen, Karlsruhe, Germany) with the different pcDNA3.1+ vectors. The cells were crosslinked with disuccinimidyl suberate (DSS) 30-48 h after transfection according to the manufacturer's protocol (Thermo Fisher Scientific). Briefly, the medium was removed and cells were washed three times in ice cold PBS-buffer (175 g, RT, 10 min) (Gibco, Thermo Fisher Scientific). The pellet was resuspended in 390 lL PBS and DSS was added at a final concentration of 2.5 mM. The reaction was carried out for 30 min at RT and stopped by the addition of 1 M Tris/HCl, pH 7.5 at a final concentration of 20 mM (RT, 15 min). For whole cell lysates, cells were centrifuged (175 g, RT, 10 min) and the supernatant was removed. The pellet was resuspended in 70 lL RIPA-buffer (50 mM Tris/HCl, pH 7.4, 1% Np-40, 0.25% deoxycholic acid sodium salt, 150 mM NaCl, 1 mM EDTA, protease inhibitor (complete mini; Roche, Mannheim, Germany)) and shaken at 4°C for 15 min. Afterwards, the lysate was centrifuged (16 000 g, 4°C, 15 min) and the supernatant was used for further examination by protein determination (Pierce BCA Protein Assay Kit; Thermo Fisher Scientific), SDS/PAGE and western blot analysis as described above.
In silico analysis and statistics
The alignment of the different FTas was performed using the program CLUSTAL OMEGA (http://www.ebi.ac.uk/Tools/ msa/clustalo/) [17] [18] [19] . The evaluation of the protein structure and the modelling of the overlay were performed with PYMOL (Schr€ odinger, LCC, The PyMOL Molecular Graphics System, Version 1.8, Mannheim, Germany). The underlying PDB files for the modelling are 4GTO for the R. norvegicus [20] and 2H6F for the Homo sapiens FTa [21] . Statistical analysis was performed using GRAPHPAD PRISM version 7.00 for Windows (GraphPad Software, La Jolla, CA, USA). Differences with P-values < 0.05 were considered significant.
Results
In silico comparison of the different FTas
The structure of a protein, which is in strong relationship with its properties, is determined by its amino acid sequence. For this reason, we investigated the differences and similarities of the already published primary and tertiary structures of the different FTas (Fig. 1) . While human and yeast FTa show only minor similarity [30% identity, query coverage of 59% (percentage of the query sequence that overlaps the subject sequence)], there is a high similarity of human and rat FTas (93% identity, 98% query coverage; Fig. 1A ) [22, 23] . Accordingly, the overlay of the two crystal structures 4GTO (R. norvegicus) and 2H6F (H. sapiens) shows high congruence of both tertiary structures (Fig. 1B) . Most of the 28 differing amino acids are located at the outer turns from one alpha helix to another (red/green parts of the crystal structure). Kubala et al. [15] used for their dimerization studies not the full-length rat FTa but an N-terminally truncated R. norvegicus FTaDN29 protein. Comparison of the human and the truncated rat protein sequence reveals still a relatively high similarity (94% identity, query coverage of 90%). However, nothing is known about the secondary and tertiary structure of this truncated rat FTa. Therefore, disparities of the already characterized FTas and the native human protein might be too big to allow a conclusion by analogy and make it necessary to further analyse the human FTa itself.
Dimerization behaviour of human FTa
To test for protein dimerization, we performed pulldown experiments. Purified GST-tagged FTa was applied to His-tagged FTa bound to Ni-NTA resin ( Fig. 2A-C, lanes W6 and E6) . Bound His-FTa [17] [18] [19] . (B) Overlay of human FTa (2H6F, dark grey) [21] and rat FTa (4GTO, light grey) [20] tertiary structures, performed with PyMOL (Schr€ odinger, LCC, The PyMOL Molecular Graphics System, Version 1.8). Green (rat) and red parts (human) indicate the differing amino acids.
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FEBS Letters 591 (2017) 3637-3648 ª 2017 Federation of European Biochemical Societies captured GST-FTa (~76 kDa; lane E6), but also native GST (~25 kDa, lane E5), while Ni-NTA resin alone was not able to capture native GST (lanes W3 and E3). The unexpected binding of GST to His-FTa might have caused a putatively artificial signal for GST-FTa. Therefore, inverted pull-downs were performed using purified His-FTa and GST-FTa bound to magnetic beads ( Fig. 2A-C, lanes W1-E2) . GST-FTa was not able to capture His-FTa (lanes W2 and E2) indicating that there is no direct interaction of the two alpha-subunits. His-FTa could only be detected after purification with a Ni-NTA column (lanes E5 and E6). A combination of His-FTb and bound GST-FTa served as positive control (Fig. S1) .
The yeast two-hybrid system was used to analyse putative in vivo interactions. Formation of the FTaFTb heterodimer served as positive control, whereas the empty vectors and accordingly one empty vector and one harbouring the FTa construct, served as negative and false-positive controls (Fig. 3A) . Blue colonies Fig. 2 . Western blots of GST and Ni-NTA pull-downs. For all tested setups, the 5th washing (W) and the 1st elution fraction (E) are shown. W1-E1: GST and FTa-His purified by MagneGST, W2-E2: FTa-GST and FTa-His purified by MagneGST, W3-E3: GST purified by Ni-NTA, W4-E4: FTa-GST purified by Ni-NTA, W5-E5: GST and FTa-His purified by Ni-NTA, W6-E6: FTa-GST and FTa-His purified by Ni-NTA. All samples were run on 12% SDS/PAGE and blotted by semidry blot. The membranes were incubated with (A) anti-GST antibody, (B) anti-His antibody and (C) anti-FTa antibody. on selective a-X-gal agar plates could only be observed when the alpha-and the beta-subunit were present (middle panel). This was additionally confirmed by a b-X-gal assay where the formation of intracellular bgalactosidase serves as an interaction indicator of the examined proteins. No blue dot was detectable when yeast cells were transformed with FTas fused to the binding and the activating domain (lower panel).
To control for very weak interactions not leading to visible blue colonies on selective agar plates or filters, a quantitative colorimetric enzyme assay adjusted for cell count was performed (Fig. 3B) . Here, the formation of p-nitrophenol (pNP) correlates with the intensity of the interaction [16] . Significant formation of pNP could only be detected when yeast cells were transformed with FTa together with FTb (both directions P < 0.001). Just like negative/false-positive controls, yeast cells transformed with FTa in both vectors did not show significantly increased pNP formation (P = 0.9998) confirming the in-gel and filter-lift assay results.
Oligomerization behaviour of human FTa
The purified human His-FTa was analysed by calibrated size-exclusion chromatography (Fig. S2A) . At least four peaks were detected at 46.6, 54.7, 70.6 and 86.3 mL. The most pronounced peak was found at 70.6 mL (calculated~110 kDa, fraction C9). This peak covered the calculated elution volume of the FTa dimer (72.8 mL, 90 kDa) and trimer (68 mL, 135 kDa). No peak could be detected at the expected elution volume of the FTa monomer (81 mL, 45 kDa). The SDS/PAGE confirmed the broad elution of different FTa conformations (68-77.5 mL, Fig. S2B , fraction C7-C18). Further analysis of the fraction C9 (top of the peak) by a native PAGE and a native western blot (Fig. S2C,D) showed four bands at the height of approx. 135, 180, 225 and 270 kDa. These tri-and higher oligomers detectable with enriched FTa prompted us to have a closer look at the self-oligomerization of the human FTa.
For better comparability of our results with those of rat FTaDN29, we performed crosslinking experiments with recombinant proteins (FTa, FTb and coexpressed FTa and FTb). The by-affinity chromatography purified proteins were incubated with the crosslinking agent BS3 and with BS3 plus b-mercaptoethanol as negative control (Fig. 4A) . The untreated and the inhibited samples of FTa showed a signal at 100 kDa which might be an unspecific band (Fig. 4A, lane 1 and 3 ). In the BS3-treated sample, there is an upshift of FTa to a molecular weight of around 180 kDa fitting to the calculated size of a tetramer (Fig. 4A, lane 2) . This band is still visible, although with a weaker signal, after inhibition of the crosslinker. There is no specific band at the calculated size of a homodimer (~90 kDa). The positive control (FTa and FTb with BS3) shows a yellow signal due to the overlay of the green and red channel, with the calculated molecular weight of the heterodimer of 92 kDa (Fig. 4A, lane 5) . There is also a weak band shifted to the FTa tetramer size that can only be seen in the green channel specific for FTa. There is no shifted band visible without crosslinking agent as well as with the inhibitor. FTb alone showed no shifting as well (Fig. 4A, lane 7-9) .
The BS3 crosslinking test still possesses an artificial environment with tagged recombinant proteins. To omit these obstacles in vivo crosslinking with tag-free proteins in an environment close to the natural habitat was performed. HEK293 cells were transfected with appropriate FTa and FTb overexpression vectors and incubated with the in vivo crosslinking agent DSS (Fig. 4B) . Since FTa is ubiquitously expressed, a weak band of endogenous FTa is detectable in lanes without overexpressed FTa (green; upper panel) [24] . Lane two shows the overexpressed alpha-subunit treated with DSS. There is no evidence for an interaction of FTa with itself since there is no upshift visible. Lane three shows an upshift to a band of the size the alpha-and the beta-subunit are supposed to have together (approx. 92 kDa) indicating an interaction of the two subunits as expected.
Analysis of full-length rat FTa
The results we obtained showed that human and truncated rat FTa have different dimerization behaviours. Since the two proteins are that identical in primary and tertiary structure, we repeated the experiments with full-length rat FTa. In vivo tests (yeast twohybrid and DSS-assay; Fig. 5A-C) show almost the same results we observed for human FTa. Only the combination of rat FTa and FTb leads to the formation of blue colonies and the pNP-assay shows no significant interaction of the FTa subunit with itself (Fig. 5A,B) . The tag-less crosslinking of the proteins with DSS shows only upshifted bands when rat FTa and FTb are present (Fig. 5C) . The in vitro experiments (size-exclusion chromatography and native PAGE) confirm these findings (Fig. 5D-F) . The elution profile of rat FTa is almost identical with the peaks of human FTa (Fig. 5D,F ) and the analysis of fraction C8 by native PAGE shows trimers and higher oligomers (Fig. 5E ).
Discussion
Our goal was to determine whether human FTa is able to self-dimerize. Our results suggest that human FTa does not form homodimers. Whilst we showed in all experiments that FTa dimerizes with FTb, it was not able to capture itself in pull-down and yeast twohybrid assays. If any, native western blot and crosslinking experiments revealed FTa trimers and higher oligomerization states, but homodimers could not be detected.
Kubala et al. [15] demonstrated that FTa of rat (DN29) and yeast each form homodimers. In contrast to this work, we were not able to show a homodimerization of human FTa. It might be possible that the selected experimental conditions were not the right ones to allow FTa-FTa dimerization. However, different lines of evidence argue against this assumption. First, to reduce the chance of false-negative findings, different well-established and independent in vitro and in vivo experimental procedures were chosen to study protein interaction with differently tagged as well as tag-free proteins [25, 26] . Second, we used BS3 crosslinking which was able to show homodimerization of rat and yeast FTas in the previous study (Fig. 4A ) [15] . Third, under the selected conditions FTa was able to interact with its well-known dimerization partner FTb in all experiments (Figs 2 and 4 ; Fig. S1 ) [12] . Fourth, FTa interacted with itself in some experiments, even though only higher oligomers could be detected (Figs 4 and S2) . Therefore, it might be possible that only rat and yeast FTas form homodimers but not the human FTa. At first glance, this appears unlikely because of the major differences between yeast and mammalian FTas and the very high homology and three-dimensional congruence of mammalian FTas (Fig. 1) . Nevertheless, it has been repeatedly reported that orthologous human and rat proteins can show very different oligomerization properties [27, 28] . Sometimes, even a small number of differing amino acids leads to pronounced differences of human and rat protein dimerization behaviours [29] . To clarify this, we repeated some of the experiments with full-length rat FTa and obtained almost the same results as we could detect for human FTa, namely no dimerization but possible trimers and higher oligomerization (Fig. 5 ). An explanation for the detected differences could be linked to an already described N-terminally located proline-rich region (residue 12-34) (Fig. 1A) . It is conserved in human and rat, but not in yeast [12] . This region is dispensable for FTase activity and is disordered in the substrate-free crystal structure (1FT1) of the rat heterodimer [30] . Previously studied yeast FTa and rat FTaDN29 lacked this seemingly nonrelevant region [15] . However, proline-rich regions are typically known for altered secondary and tertiary protein structures [31] and can have a major impact on the binding behaviour of proteins [32] . Therefore, it suggests itself as a candidate for further studies to evaluate the putative Some of our experiments revealed the formation of homo-oligomers (Fig. 4 and S2) . Strikingly, this was only observable in in vitro tests with enriched and purified FTa. A reason for this might be an artificial oligomerization due to the abundant protein excess. Some proteins are known to show an altered oligomerization behaviour when the protein concentration is very high [33] . Naturally, FTa shows a strong interaction with the ubiquitously expressed FTb [24, 34] . It has been described that such proteins forming normally a stable heterodimer are sometimes prone to form artificial homo-oligomers in absence of its physiological partner [35] [36] [37] [38] . Unfortunately, crystal structures of the substrate-free human FTase as well as of human, rat or yeast FTa alone are not available until now, but 14 already published ligand-bound human FTase structures of the RCSB protein data bank are described without a hint for homo-oligomerization [39] .
Although the overall function of FTase and GGTase I as well as their substrates are well characterized, the precise task of FTa remains unclear. It is highly evolutionary conserved, stabilizes the beta-subunits and seems to be directly involved in enzymatic activity and regulation [12] [13] [14] . The recently detected homodimerization of rat (DN29) and yeast FTa and its putative role for interaction with further proteins broadened the view substantially [15] . We show here for the first time, that this homodimerization might be species-specific. This leads to the question whether some of the other previously identified functions could be species-dependent as well. Furthermore, it might be a new starting point to investigate the failure of FTase inhibitors in humans [40] . Until now, we and others focused especially on intraspecies differences to explore the weak or absent success of these inhibitors in cancer [41] [42] [43] . Investigation of relevant physiological differences between yeast and mammalian FTas would be a new approach to understand and interpret previous results. Moreover, FTase inhibitors are currently under investigation for many other malignancies, for example hepatitis D, progeria, cancer, mycosis and malaria [44] [45] [46] [47] [48] . Therefore, further clarification of the physiological features of FTase in different species would be a substantially contribution and maybe a requirement for the ongoing development of FTase inhibitors.
In summary, we show here for the first time that human FTa and full-length rat FTa do not form homodimers. Our work implies a relevant species-specific difference to yeast FTa. This is a very important finding that can lead to better understanding of FTase regulation and function. FTa dimerization should be further investigated because of the relevant role of FTase in many physiological and pathophysiological processes.
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